John York, PharmD, MBA

Principal & CEO,

AKITA BIOMEDICAL

Lecturer,

RADY, IGE/JACOBS (UCSD), ORFALEA COLLEGE OF BUSINESS, CAL POLY, SLO

Adj. Professor

ERNEST MARIO (RUTGERS)

John M. York, PharmD, MBA brings over 30 years in the biopharmaceutical business. After receiving his doctorate in pharmacy from the University of Michigan, York was the first graduate of the Rutgers Pharmaceutical Industry Fellowship program. He also completed his MBA at Kelley School of Business (Indiana University) and certificates in Life Science Business Management and Marketing through UC Berkeley.

His industry career included increasing roles of responsibility at Bristol-Myers Squibb, Amgen, Allergan, and HDI. York has started three businesses, including Akita Biomedical, MD Eyecare, and Ophthalmic Research and Education Consultants. He currently serves on the scientific board for JD Biosciences. Akita, a 20-year-old medical communications and strategy firm, has engaged with various life science firms (from startups to large multinationals) via publication programs, advisory boards, education programs, market research, and business planning. He has taught at the Orfalea College of Business (Cal Poly, San Luis Obispo), the Rady School of Management and Jacobs School of Engineering at UC, San Diego, and the Ernest Mario School of Pharmacy.

York has served in faculty and mentor roles at Ahmedabad University, the University of Tsukuba, the ANHS ScaleUp HealthCare Academy, the Global Entrepreneurship Accelerator program for Korea, and the National Science Foundation I-CORPS™ program at UC, San Diego, and the Arab Academy program at Cal Poly. His current teaching responsibilities include being the co-director of the capstone projects class for the translational medicine certificate program, lead instructor for the Institute for the Global Entrepreneur at UC, San Diego, and consultant faculty at the Ernest Mario School of Pharmacy Rutgers Pharmaceutical Industry Fellowship program. He has authored over 35 publications (with 22 in business and entrepreneurship) personally, with over 160 (including 14 translational medicine articles) for various clients. He is currently pursuing a doctorate in business administration at the Cranfield School of Management in the United Kingdom, focusing on entrepreneurship and strategy.